Sulfonylureas, biguanides and thiazolidinediones are classes of antidiabetic drugs whose mechanisms of action, such as enhancing insulin action and secretion, describe the pathophysiology of T2D [94]. This evidence concerns the gene INS and type 2 diabetes mellitus.